GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value ($000): $232,821 (100.0% shares, 0.0% debt)

Holdings (37)

HYPERION THERAPEUTICS INC 8.6%
Value ($000) $20,021 Shares 793,864 Est. Cost $25.97 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 7.8%
Value ($000) $18,204 Shares 1,161,739 Est. Cost $15.34 Unrealized -2.6%
INFIQ INFINITY PHARMACEUTICALS INC 6.3%
Value ($000) $14,762 Shares 1,100,000 Est. Cost $12.26 Unrealized -2.9%
ALIMERA SCIENCES INC 6.1%
Value ($000) $14,200 Shares 2,619,853 Est. Cost $6.86 Unrealized
OPHTHOTECH CORP 5.0%
Value ($000) $11,679 Shares 300,000 Est. Cost $41.75 Unrealized
ENDOLOGIX INC 4.4%
Value ($000) $10,316 Shares 973,200 Est. Cost $11.52 Unrealized
DERMA SCIENCES INC 4.2%
Value ($000) $9,676 Shares 1,161,604 Est. Cost $12.41 Unrealized
ARADIGM CORP CMN 4.2%
Value ($000) $9,667 Shares 1,008,062 Est. Cost $8.85 Unrealized
AMBIT BIOSCIENCES CORP 4.0%
Value ($000) $9,240 Shares 600,000 Est. Cost $12.77 Unrealized
OCERA THERAPEUTICS INC 3.9%
Value ($000) $9,111 Shares 1,859,315 Est. Cost $6.19 Unrealized
OM2 ORTHOFIX INTL N V 3.5%
Value ($000) $8,200 Shares 264,873 Est. Cost $31.18 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 3.4%
Value ($000) $7,917 Shares 2,474,076 Est. Cost $3.55 Unrealized 0.0%
EXEL EXELIXIS INC 3.4%
Value ($000) $7,803 Shares 5,100,000 Est. Cost $3.21 Unrealized 0.0%
ALCOBRA LTD 3.2%
Value ($000) $7,522 Shares 487,200 Est. Cost $17.94 Unrealized
ONCOTHYREON INC 3.2%
Value ($000) $7,503 Shares 3,907,952 Est. Cost $2.14 Unrealized
PAIN THERAPEUTICS INC 3.1%
Value ($000) $7,108 Shares 1,817,889 Est. Cost $2.80 Unrealized
AASTROM BIOSCIENCES INC 2.7%
Value ($000) $6,185 Shares 2,170,000 Est. Cost $2.85 Unrealized
EBS EMERGENT BIOSOLUTIONS INC 2.7%
Value ($000) $6,180 Shares 290,000 Est. Cost $22.90 Unrealized 0.0%
VCYT VERACYTE INC 2.5%
Value ($000) $5,921 Shares 607,296 Est. Cost $13.38 Unrealized -1.9%
HEARTWARE INTL INC 2.3%
Value ($000) $5,434 Shares 70,000 Est. Cost $77.63 Unrealized
ONCOGENEX PHARMACEUTICALS IN 2.1%
Value ($000) $4,790 Shares 1,793,942 Est. Cost $3.73 Unrealized
SOPHIRIS BIO INC 2.0%
Value ($000) $4,646 Shares 1,585,500 Est. Cost $4.38 Unrealized
TENAX THERAPEUTICS INC 1.9%
Value ($000) $4,384 Shares 1,115,497 Est. Cost $3.93 Unrealized
VICAL INC 1.5%
Value ($000) $3,388 Shares 3,025,000 Est. Cost $1.19 Unrealized
CUTERA INC 1.4%
Value ($000) $3,182 Shares 315,000 Est. Cost $10.38 Unrealized
SUNESIS PHARMACEUTICALS INC 1.2%
Value ($000) $2,856 Shares 400,000 Est. Cost Unrealized
ANTHERA PHARMACEUTICALS INC 1.2%
Value ($000) $2,748 Shares 1,431,196 Est. Cost $3.35 Unrealized
CHEMOCENTRYX INC 0.9%
Value ($000) $2,177 Shares 483,741 Est. Cost $4.50 Unrealized
WAFERGEN BIO-SYSTEMS INC 0.8%
Value ($000) $1,834 Shares 421,509 Est. Cost $4.35 Unrealized
ONCONOVA THERAPEUTICS INC 0.6%
Value ($000) $1,487 Shares 345,824 Est. Cost $4.66 Unrealized
MEI PHARMA INC 0.5%
Value ($000) $1,088 Shares 157,661 Est. Cost $11.25 Unrealized
AMARIN CORP PLC 0.4%
Value ($000) $1,007 Shares 923,534 Est. Cost $1.09 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.3%
Value ($000) $702 Shares 151,611 Est. Cost $6.45 Unrealized
THORATEC CORP 0.3%
Value ($000) $596 Shares 22,300 Est. Cost $34.86 Unrealized
ALCOBRA LTD 0.2%
Value ($000) $559 Shares 36,200 Est. Cost $17.94 Unrealized
CARA THERAPEUTICS INC 0.2%
Value ($000) $397 Shares 47,321 Est. Cost $18.44 Unrealized
ZAFGEN INC 0.1%
Value ($000) $331 Shares 16,855 Est. Cost $19.64 Unrealized